MRES (Institute of Biomedical Research) ROCE %: 0.00% (As of Dec. 2010)

What is Institute of Biomedical Research ROCE %?

Institute of Biomedical Research MRES ROCE % is 0.00% as of Dec. 2010.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Institute of Biomedical Research's annualized ROCE % for the quarter that ended in Dec. 2010 was 0.00%.

Institute of Biomedical Research (OTCPK:MRES) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Institute of Biomedical Research ROCE % Related Terms

Institute of Biomedical Research ROCE % Historical Data

* Premium members only.

The historical data trend for Institute of Biomedical Research's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Institute of Biomedical Research ROCE % Chart

Institute of Biomedical Research Annual Data

Trend

Dec03

Dec04

Mar06

Mar07

Mar08

Mar09

Mar10

ROCE %

Get a 7-Day Free Trial

0.00

Institute of Biomedical Research Quarterly Data
	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10
ROCE %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

Institute of Biomedical Research ROCE % Calculation

Institute of Biomedical Research's annualized ROCE % for the fiscal year that ended in Mar. 2010 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2010 )		(A: Mar. 2009 )		(A: Mar. 2010 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2010 )		(A: Mar. 2009 )		(A: Mar. 2010 )
	=	-0.262	/	( ( (0.078 - 0.149)	+	(0.076 - 0.422) )	/ 2 )
	=	-0.262	/	( (-0.071	+	-0.346)	/ 2 )
	=	-0.262	/	-0.2085
	=	125.66 %

Institute of Biomedical Research's ROCE % of for the quarter that ended in Dec. 2010 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2010 )		(Q: Sep. 2010 )		(Q: Dec. 2010 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2010 )		(Q: Sep. 2010 )		(Q: Dec. 2010 )
	=	-0.072	/	( ( (0.668 - 1.654)	+	(0.655 - 0.461) )	/ 2 )
	=	-0.072	/	( ( -0.986	+	0.194 )	/ 2 )
	=	-0.072	/	-0.396
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2010) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 0.00% mean?

Institute of Biomedical Research (MRES) has a ROCE % of 0.00% as of Dec. 2010.

Is Institute of Biomedical Research's ROCE % too high?

Institute of Biomedical Research's current ROCE % is 0.00%.

How does Institute of Biomedical Research's ROCE % compare to HSTC and NTRR?

Institute of Biomedical Research's ROCE % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Biotechnology company?

A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. Institute of Biomedical Research's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Institute of Biomedical Research stock overvalued right now?

Institute of Biomedical Research (MRES) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Institute of Biomedical Research (MRES), the current ROCE % is 0.00% as of Dec. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Institute of Biomedical Research Business Description

Industry Healthcare Biotechnology

Comparable Companies HSTC NTRR VITIF TLOG NSPX ERGO OPLI GLAG FPMI ADYNF ENTB CAPS BTHE GOVX LCAR IMUC CTBO GNBT ICOTF TIKRF

Address Dubai Science Park, 13th Floor, South Tower, Dubai, ARE, 416452

Website https://www.m2bio.co

Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.